ArticleInternational journal of nephrology2026
Chronic Kidney Disease in Urban, Adult Sri Lankans: A Cohort Follow-Up Study.
Article in International journal of nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chronic Kidney Disease in Urban, Adult Sri Lankans: A Cohort Follow-Up Study.International journal of nephrology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease (CKD) affects approximately 850 million adults worldwide, with its prevalence rising due to increasing rates of diabetes and hypertension in aging populations. This study aims to assess the prevalence and associated factors of CKD in an urban adult cohort in Sri Lanka, where such data are limited. Methods: We conducted a stratified random sampling of participants from Ragama, Sri Lanka, initially in 2007 (ages 35-64) and reassessed them in 2014. Data collection involved structured interviews, anthropometric measurements, and biochemical tests. CKD was evaluated in 2014 using the estimated glomerular filtration rate (eGFR) calculated via the CKD-EPI formula, defining CKD as eGFR < 60 mL/min/1.72 m Results: Of 2985 individuals recruited in 2007, 2148 (71.6%) participated in the 2014 follow-up; 2032 (94.6%) had complete data to assess CKD status in 2014. Mean age of the participants was 52.3 (SD 7.7) years; 57% were women. Age-adjusted prevalence of CKD was 3.03 (1.98-4.11) per 100 population in 2014; most were Stage 3A (67.2%), followed by Stage 3B (23%) and Stage 4 (9.8%). Older age ( Conclusions: Diabetes and hypertension are significant contributors to CKD prevalence, with most patients at Stage 3, where early detection and management can slow disease progression. CKD remains underrecognized in Sri Lanka, highlighting the need for extensive population-based studies to better understand this growing health issue better.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.